Comparative analysis of global practices in the management of colchicine-resistant familial Mediterranean fever: a CliPS network analysis

Background Although colchicine is the mainstay of familial Mediterranean fever (FMF) treatment, 5–10% of patients are considered to have colchicine resistance (CR). However, there is no globally agreed CR definition or indications for biological disease-modifying anti-rheumatic drugs (bDMARDs).Metho...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michael Hofer, Veronique Hentgen, Anna Mamutova, Tamàs Constantin, Mario Sestan, Rim Bourguiba, Marion Delplanque, Helmut Wittkowski, Helen Lachmann, Jürgen Brunner, Roberta Caorsi, Muserref Kasap Cuceoglu, Konstantinos Pateras, Betul Sozeri, Inès Elhani, Stefan Backes, Fatih Haslak, Nimet Oner, Tanja Hinze, Yonatan Butbul Aviel, Stéphanie Ducharme Bénard, Majdouline El Moussaoui, Meri Kirijas, Sonia Carriquí Arenas, Ghalia Khellaf, Vafa Guliyeva, Naiera Assalia, Nuray Ayaz
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-09-01
coleção:	RMD Open
Acesso em linha:	https://rmdopen.bmj.com/content/11/3/e006097.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!